Measuring and modelling the effects of systematic non-adherence to mass drug administration

Highlights • We review models of systematic non-adherence and propose a new model for the effect.• We use two simplified models to explore the effects of systematic non-adherence.• We find that systematicness has a significant impact on the campaign outcome.• The number of rounds attended can be analysed to find the level of systematicness.• In published data the correlation between treatment rounds is between 0.281and 0.535.

• Publication year

  2017

• Venue

  Epidemics

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.epidem.2017.02.002PMID 28279457PMCID 5340860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission

  2017influential reference
• Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results

  2016cited by this paper
• Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two ‘Endgame’ Districts in Indonesia Using Micronarrative Surveys

  2016cited by this paper
• Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review

  2016influential reference
• Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators

  2016cited by this paper
• Abundance and seasonal activity of Haemaphysalis concinna (Acari: Ixodidae) at the border between China and Russia in Northern Inner Mongolia, China

  2016cited by this paper
• Sm16, a major component of Schistosoma mansoni cercarial excretory/secretory products, prevents macrophage classical activation and delays antigen processing

  2015cited by this paper
• What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?

  2015cited by this paper
• Evaluating long-term effectiveness of sleeping sickness control measures in Guinea

  2015cited by this paper
• What impact will the achievement of the current World Health Organisation targets for anthelmintic treatment coverage in children have on the intensity of soil transmitted helminth infections?

  2015influential reference
• Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination

  2015influential reference
• Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis

  2015influential reference
• Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa

  2015influential reference
• Global elimination of leprosy by 2020: are we

  2015cited by this paper
• Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework

  2015cited by this paper
• Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals

  2015cited by this paper
• Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis

  2015influential reference
• The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data

  2015cited by this paper
• Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases

  2015cited by this paper
• Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection

  2015cited by this paper
• Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo

  2015cited by this paper
• Characterization of Severe Fever with Thrombocytopenia Syndrome in Rural Regions of Zhejiang, China

  2014cited by this paper
• Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment

  2014cited by this paper
• The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study.

  2014cited by this paper
• Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa

  2014cited by this paper
• Turner HC, Walker M, Churcher TS, Basáñez MG. Modelling the Impact of Ivermectin on River Blindness and its Burden of Morbidity and Mortality in African Savannah: EpiOncho Projections

  2014cited by this paper
• Sustaining the drive to overcome the global impact of neglected tropical diseases : second WHO report on neglected tropical diseases

  2013cited by this paper
• A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

  2013cited by this paper
• Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis

  2013cited by this paper
• Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India

  2013cited by this paper
• WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA

  2012cited by this paper
• Optimisation of mass chemotherapy to control soil-transmitted helminth infection.

  2012cited by this paper
• Characteristics of persons who complied with and failed to comply with annual ivermectin treatment

  2012cited by this paper
• Should I Get Screened for Sleeping Sickness? A Qualitative Study in Kasai Province, Democratic Republic of Congo

  2012cited by this paper
• Global programme to eliminate lymphatic filariasis: progress report, 2011.

  2012cited by this paper
• Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda

  2011cited by this paper
• Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria

  2011cited by this paper
• Improving community participation to eliminate lymphatic filariasis in American Samoa.

  2011cited by this paper
• The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria

  2011cited by this paper
• Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

  2010influential reference
• A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti

  2010cited by this paper
• Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods.

  2009cited by this paper
• LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages

  2008cited by this paper
• The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

  2007influential reference
• Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up.

  2007influential reference
• Participation in three consecutive mass drug administrations in Leogane, Haiti

  2006influential reference
• The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India

  2004cited by this paper
• Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.

  2003cited by this paper
• A family of multivariate binary distributions for simulating correlated binary variables with specified marginal means and correlations

  2003cited by this paper
• Can ivermectin mass treatments eliminate onchocerciasis in Africa?

  2002cited by this paper
• Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.

  2000cited by this paper
• Population biology of human onchocerciasis.

  1999cited by this paper
• The LYMFASIM Simulation Program for Modeling Lymphatic Filariasis and its Control

  1998cited by this paper
• Effect of mass treatments with ivermectin, with only partial compliance, on prevalence and intensity of O. volvulus infection in adults and in untreated 4 and 5 year‐old children in Burundi

  1997influential reference
• SCHISTOSIM: a microsimulation model for the epidemiology and control of schistosomiasis.

  1996cited by this paper
• A cost-effectiveness analysis of anthelminthic intervention for community control of soil-transmitted helminth infection: levamisole and Ascaris lumbricoides.

  1996cited by this paper
• ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.

  1990cited by this paper
• Exact Stochastic Simulation of Coupled Chemical Reactions

  1977cited by this paper

• Point participation does not reflect long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis transmission focus, Wenchi, Ghana.

  2026cites this paper
• Exploring the landscape of lymphatic filariasis research in India: A scientometric analysis of two decades from 2000 to 2024

  2026cites this paper
• Modelling of onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment.

  2026cites this paper
• Vector-borne helminthiases: a road map for current and future research to support control and elimination in sub-Saharan Africa.

  2025cites this paper
• Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study

  2025cites this paper
• HISTONCHO: A database of intervention histories for onchocerciasis control & elimination in sub-Saharan Africa

  2025cites this paper
• Mass drug administration coverage and its determinants for the elimination of onchocerciasis in Ulanga District, Tanzania

  2025cites this paper
• Pre-school Age Participation in Mass Drug Administration: Analysing the Impact on Community-wide Schistosomiasis Control

  2025cites this paper
• Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in Cameroon between 1971 and 2020

  2025cites this paper
• Integrating social and behavior change communication into mass drug administration campaigns for neglected tropical diseases: insights and best practices from Jimma, Ethiopia

  2025cites this paper
• High Levels of Community Support for Mansonellosis Interventions in an Endemic Area of the Brazilian Amazon

  2025cites this paper
• Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis

  2024cites this paper
• Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study

  2024cites this paper
• How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis

  2024cites this paper
• Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study

  2024cites this paper
• Uncertainty Quantification in Cost-effectiveness Analysis for Stochastic-based Infectious Disease Models: Insights from Surveillance on Lymphatic Filariasis

  2024cites this paper
• Dose-Dependent Prophylactic Efficacy of Filarial Antigens Glutathione-S-Transferase and Abundant Larval Transcript-2 against Brugia malayi Challenge in Mastomys

  2024cites this paper
• Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti

  2024influential citation
• Socio-ecological heterogeneity and uncertainty in the elimination of human schistosomiasis

  2024cites this paper
• Modeling the persistence of Opisthorchis viverrini worm burden after mass-drug administration and education campaigns with systematic adherence

  2024cites this paper
• Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa

  2023cites this paper
• How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?

  2023cites this paper
• How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?

  2023cites this paper
• Persons ‘never treated’ in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020–2021

  2023cites this paper
• How correlations between treatment access and surveillance inclusion impact neglected tropical disease monitoring and evaluation—A simulated study

  2023cites this paper
• How important is the spatial movement of people in attempts to eliminate the transmission of human helminth infections by mass drug administration?

  2023cites this paper
• Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration

  2023cites this paper
• Pre-clinical development of a vaccine for human lymphatic filariasis

  2022cites this paper
• Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children

  2022cites this paper
• Assessment of factors related to individuals who were never treated during mass drug administration for lymphatic filariasis in Ambon City, Indonesia

  2022cites this paper
• Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic review

  2022cites this paper
• Longitudinal monitoring of prevalence and intensity of soil-transmitted helminth infections as part of community-wide mass drug administration within the Geshiyaro project in the Bolosso Sore district, Wolaita, Ethiopia

  2022cites this paper
• Public Health Policy Pillars for the Sustainable Elimination of Zoonotic Schistosomiasis

  2022cites this paper
• Modelling the Impact of Vector Control on Lymphatic Filariasis Programs: Current Approaches and Limitations

  2021cites this paper
• Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review

  2021cites this paper
• Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies

  2021cites this paper
• Antimalarial mass drug administration in large populations and the evolution of drug resistance

  2021cites this paper
• Probability distributions of helminth parasite burdens within the human host population following repeated rounds of mass drug administration and their impact on the transmission breakpoint

  2021cites this paper
• Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment

  2021cites this paper
• EVALUATION OF PROPHYLACTIC ADEQUACY OF FILARIAL RECOMBINANT PROTEIN (rBmALT-2) WITH MONOPHOSPHORYL LIPID A (MPLA) ADJUVANT

  2021cites this paper
• How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases

  2021cites this paper
• Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?

  2021cites this paper
• Statistical analysis of one-compartment pharmacokinetic models with drug adherence

  2021cites this paper
• How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases [version 1; peer review: awaiting peer review]

  2021cites this paper
• Individual adherence to mass drug administration in neglected tropical disease control: A probability model conditional on past behaviour

  2021cites this paper
• Schistosomiasis Control: Leave No Age Group Behind.

  2020cites this paper
• Filariasis Vulnerability Zonation Based on Environmental and Behavioural Aspects in Pekalongan City, Indonesia

  2020cites this paper
• Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination

  2020cites this paper
• Cost-effectiveness of combining drug and environmental treatments for environmentally transmitted diseases

  2020cites this paper
• Modeling Treatment Strategies to Inform Yaws Eradication

  2020cites this paper
• Dynamics of individual adherence to mass drug administration in a conditional probability model

  2020cites this paper
• The impact of community-wide, mass drug administration on aggregation of soil-transmitted helminth infection in human host populations

  2020cites this paper
• Dynamics of COVID-19 under social distancing measures are driven by transmission network structure

  2020cites this paper
• Insights from mathematical modelling and quantitative analysis on the proposed 2030 goals for trachoma

  2019cites this paper
• Operating Characteristic (ROC) curve

  2019cites this paper
• Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold

  2019cites this paper
• Insights from quantitative analysis and mathematical modelling on the proposed WHO 2030 goals for soil-transmitted helminths

  2019cites this paper
• Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs

  2019cites this paper
• The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling

  2019cites this paper
• The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling

  2019cites this paper
• Insights from quantitative and mathematical modelling on the proposed 2030 goals for Yaws

  2019cites this paper
• Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison

  2019cites this paper
• Insights from mathematical modelling on the proposed WHO 2030 goals for scabies

  2019cites this paper
• Programmatic goals and spatial epidemiology influence the merit of targeted versus of population-wide interventions for yaws eradication

  2019cites this paper
• MECHANISTIC AND STATISTICAL MODELS OF SKIN DISEASE TRANSMISSION

  2019cites this paper
• A Call for Systems Epidemiology to Tackle the Complexity of Schistosomiasis, Its Control, and Its Elimination

  2019cites this paper
• Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana

  2019cites this paper
• Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination

  2019cites this paper
• Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review

  2018cites this paper
• How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control

  2018cites this paper
• Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?

  2018cites this paper
• Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination

  2018cites this paper
• Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis

  2018influential citation
• Helminth lifespan interacts with non-compliance in reducing the effectiveness of anthelmintic treatment

  2018cites this paper
• Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance

  2018cites this paper
• Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.

  2018cites this paper
• Kernel-density estimation and approximate Bayesian computation for flexible epidemiological model fitting in Python

  2018cites this paper
• Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections

  2018cites this paper
• Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns

  2018cites this paper
• 100 Years of Mass Deworming Programmes: A Policy Perspective From the World Bank's Disease Control Priorities Analyses.

  2018cites this paper
• Learning from multi-model comparisons: Collaboration leads to insights, but limitations remain.

  2017cites this paper
• The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis

  2017cites this paper
• Prospects for elimination of soil-transmitted helminths

  2017cites this paper
• The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission

  2017cites this paper
• A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.

  2016cites this paper